Clients
FDR works with nearly 300 companies, research institutions and investors in the life sciences located throughout the United States, Canada and Europe. The following list is representative of the kinds of clients we serve.
|
Drug Discovery/Development
3-V Biosciences
Alnylam Pharmaceuticals
Archemix
Avila Therapeutics
Cerulean Pharma
Concert Pharmaceuticals
Constellation Pharmaceuticals
Cougar Biotechnology
Dyax
Eisai Research Institute
Genocea
Gloucester Pharmaceuticals
GPC Biotech
Link Medicine
Lux Biosciences
Makoto Life Sciences
Niiki Pharma
Nora Therapeutics
Ophthotech
Portola Pharmaceuticals
Seaside Therapeutics
Solasia Pharma
Stromedix
Vitae Pharmaceuticals
Xenome
|
Marketed Pharmaceuticals
Access Pharmaceuticals
Cubist Pharmaceuticals
Endo Pharmaceuticals
GTC Biotherapeutics
Healthcare Brands International
Idenix Pharmaceuticals
Millennium The Takeda Oncology Company
Mutual Pharmaceutical Company
Biotech Plants, Fuels, Food and Supplements
Evogene
Martek Biosciences
Services for Life Sciences Companies
Genexion
Hovione
Medichem
PDI
|
| |
Medical Devices, Diagnostics, Materials and Tools
Arbios Systems
Cambridge Polymer Group
Flex Biomedical
Genstruct
Heartscape Technologies
Ikonisys
Interventional and Surgical Innovations
Modular Genetics
PerkinElmer
Primera Biosystems
SmartCells
Xemed
|
Venture Capital and Private Equity
Abingworth Management
Atlas Venture
Endurance Investments
Lakeview Capital Management
Latin America Pharma
Lux Capital Management
Novo A/S
Polaris Venture Partners
PureTech Ventures
Third Rock Ventures
Trevi Health Ventures
|
| |
Academic/Research Institutions/Foundations
CAVU Foundation
Children’s Hospital Boston
Harvard University
Tufts University
Yissum – Hebrew University (Jerusalem)
|
|
| |
